2006
DOI: 10.1002/mrm.20996
|View full text |Cite
|
Sign up to set email alerts
|

In vivo cellular imaging of lymphocyte trafficking by MRI: A tumor model approach to cell‐based anticancer therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

8
85
0
6

Year Published

2007
2007
2021
2021

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 92 publications
(99 citation statements)
references
References 35 publications
8
85
0
6
Order By: Relevance
“…Moreover, to make the study more relevant, concentrations were selected that resembled doses at which these NPs are used for human applications. An IC 20 (concentrations that lead to 20% loss in viability) value for 24 h incubation was considered, as in all three cases, MCM-41 (100 µg/mL) 27,28 Fe 2 O 3 (100 µg/mL) 29,30 and ZnO (12.5 µg/ mL) 31,32 the concentrations chosen were within the range used for biomedical or other applications.…”
Section: Resultsmentioning
confidence: 99%
“…Moreover, to make the study more relevant, concentrations were selected that resembled doses at which these NPs are used for human applications. An IC 20 (concentrations that lead to 20% loss in viability) value for 24 h incubation was considered, as in all three cases, MCM-41 (100 µg/mL) 27,28 Fe 2 O 3 (100 µg/mL) 29,30 and ZnO (12.5 µg/ mL) 31,32 the concentrations chosen were within the range used for biomedical or other applications.…”
Section: Resultsmentioning
confidence: 99%
“…Because nonspecifi c internalization by T cells is ineffi cient, contrast labeling of those cells requires tagging with internalization enhancers such as peptides or specifi c ligands that facilitate the internalization of the contrast agent without compromising cellular function. A variety of these internalization enhancers have been proposed and used effectively, including HIV tat peptides (which can increase T-cell uptake of liposomal 33 and iron oxide nanoparticles 34 100-fold compared with unlabeled contrast agent), anionic iron oxide nanoparticles, 35 and transfection reagents combined with the contrast agent. 36 But while supermagnetic iron oxide (SPIO) and gadoliniumbased agents are well-established, safe, and effective MR contrast agents, little has been achieved from the standpoint of incorporating these contrast agents into drug delivery vehicles for targeting specifi c T cells.…”
Section: Tracking T-cell Trafficking and Migrationmentioning
confidence: 99%
“…However, we found the content of accumulated Fe in the grafts to be a little bit lower than expected. Smirnov et al reported 37 that PB staining stained only a fraction (Fe 3+ ) of the studied particles (Fe 3+ and Fe 2+ ) and that some labeled cells were probably undetected, but detectable by MRI. We think this might be the explanation of our results.…”
Section: Discussionmentioning
confidence: 96%